What is SYPR's health score?

SYPRIS SOLUTIONS INC (SYPR) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SYPR's estimated fair value?

Based on our 5-year discounted cash flow model, SYPRIS SOLUTIONS INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is SYPR undervalued or overvalued?

Our model currently rates SYPR as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

SYPRIS SOLUTIONS INC (SYPR)

Healthcare Inconclusive inconclusive weak

$2.04

Updated: 2026-07-16

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

40 Weak

Relative Value

20 Stressed

Capital Allocation

55 Mixed

Risk Management

50 Mixed

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

Industry Related Stocks

AGILENT TECHNOLOGIES, INC. (A) ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) AUTOSCOPE TECHNOLOGIES CORP (AATC) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.